SO
ABOS icon

STRS Ohio’s Acumen Pharmaceuticals ABOS Stock Holding History

STRS Ohio’s Portfolio ABOS Stock Details ABOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-41,300
Closed -$161K – 2028
2022
Q1 		$161K Buy
41,300
+8,000
+24% +$43.5K ﹤0.01% 1763
2021
Q4 		$225K Buy
33,300
+31,100
+1,414% +$342K ﹤0.01% 1703
2021
Q3 		$32K Buy
+2,200
New +$36.6K ﹤0.01% 2131

Other funds holding ABOS

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
GPC
Guardian Point Capital Charlottesville, Virginia $243M AUM 22.43% 1-Year Est. Return

STRS Ohio's ABOS Position: Q2 2022 in Review

STRS Ohio sold out of Acumen Pharmaceuticals (ABOS) in Q2 2022, closing a stake of 41,300 shares — an estimated $161K sold.

STRS Ohio first reported a position in ABOS in Q3 2021 and held it in 3 quarters. The position peaked at $225K in Q4 2021. 47 funds tracked by Wall St. Rank hold ABOS as of Q2 2022.

  • STRS Ohio reported no remaining Acumen Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
  • STRS Ohio sold 41,300 Acumen Pharmaceuticals shares in Q2 2022, an estimated $161K.
  • STRS Ohio first reported a position in Acumen Pharmaceuticals in Q3 2021 and held it in 3 quarters.
  • STRS Ohio's Acumen Pharmaceuticals position peaked at $225K in Q4 2021.
  • 47 funds tracked by Wall St. Rank held Acumen Pharmaceuticals as of Q2 2022.

Based on STRS Ohio's 13F filing for Q2 2022, filed 25 Jul 2022.